← All trials
NCT06256523
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 29, 2022
- Primary completion
- Sep 28, 2023
- Completion date
- Sep 28, 2023
- First posted
- Feb 13, 2024
- Last posted
- Feb 23, 2024
- Enrollment
- 72
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gan and Lee Pharmaceuticals, USALead sponsor
- Gan and Lee Pharmaceuticals, USAOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.